Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines.
about
Sample preparation techniques for the untargeted LC-MS-based discovery of peptides in complex biological matricesHigh circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.HCSD: the human cancer secretome databaseADAM-17: the enzyme that does it all.Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas.Investigations on the usefulness of CEACAMs as potential imaging targets for molecular imaging purposes.Quantitative analysis of the secretome of TGF-beta signaling-deficient mammary fibroblasts.Identification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics.Bioinformatic identification of proteins with tissue-specific expression for biomarker discoveryFollistatin is a novel biomarker for lung adenocarcinoma in humans.Lung cancer signature biomarkers: tissue specific semantic similarity based clustering of digital differential display (DDD) data.Pathogen recognition by the long pentraxin PTX3.Prioritization of cancer marker candidates based on the immunohistochemistry staining images deposited in the human protein atlas.Biological functions of thyroid hormone in placentaIntegrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.Proteomic analysis of media from lung cancer cells reveals role of 14-3-3 proteins in cachexia.Differentially expressed and activated proteins associated with non small cell lung cancer tissuesStable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells.Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned mediumThe prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer.Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.Methodologies to decipher the cell secretome.Pentraxin 3: an immuno-regulator in the lungs.Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas.Lifestyle intervention is associated with decreased concentrations of circulating pentraxin 3 independent of CRP decrease.Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissuesIn-depth analysis of secretome and N-glycosecretome of human hepatocellular carcinoma metastatic cell lines shed light on metastasis correlated proteins.Respiratory Proteomics Today: Are Technological Advances for the Identification of Biomarker Signatures Catching up with Their Promise? A Critical Review of the Literature in the Decade 2004-2013.Non-small-cell lung cancer cell lines A549 and NCI-H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane.Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines.Cancer proteomics.Advances in membrane proteomics and cancer biomarker discovery: current status and future perspective.Exoproteomics: exploring the world around biological systems.Glycocapture-based proteomics for secretome analysis.The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules.Pentraxin-3 as a prognostic marker in patients with small-cell lung cancer.Proteomic profiling of the cancer cell secretome: informing clinical research.Ionizing radiation induces a motile phenotype in human carcinoma cells in vitro through hyperactivation of the TGF-beta signaling pathway.
P2860
Q21296806-44FBD2D6-3AD2-4BA8-AFEB-4296A5554F8DQ27853357-53D650F7-FBE7-4B40-9C5F-0F0A05DD9346Q28647947-CC9A9A4E-809F-451C-8BEA-30EFCD27EDDBQ33737421-62535738-4952-4A3D-9A82-8C96899520BCQ33883005-FC922F67-5216-47E2-B0BB-AA32AE263FACQ34097582-CEBE78DB-CE6F-45DA-8EC1-6A6B587A6660Q34145178-CFFB7060-FCF3-4D79-BAAC-A7B1F37397FAQ34148738-639F7D13-2A1F-4250-B207-164F4D23C976Q34239193-3CB4C7C8-F763-418D-A387-C0376B25B3FCQ34408498-7A324866-BA25-47F8-A0DE-D3DB6AE735D8Q34466055-335DEF7F-6C15-4FFD-B2EA-F38F75428B26Q35054493-56291141-D597-46E1-95D5-9B54B45E2CF3Q35058538-61787FE4-C4EB-4FB0-8893-727E6C73E320Q35139213-8134302F-86C5-44FA-8C19-EA288EE2DF64Q35497551-5331572A-C584-41FF-B076-20C929FCE827Q35545361-AB69F691-A8B3-445B-B54F-B6D32A268AD2Q35805319-03080A84-96BF-40CE-90B0-A511D8316221Q35878747-98DB0BB4-2B7C-44A0-9C05-409389779BFEQ35957217-B5549EFA-0386-4B45-AD04-75306636A4BBQ36121363-88957ECA-D816-43E1-9D6C-A08626FCD33EQ36386860-230DE13D-ECBC-49DE-8CA4-B2245B46D268Q36840490-EC87468D-0254-4ACF-B44A-31390858CF58Q36889123-7E1F760B-5EFF-4803-BE39-174AB9E631E8Q36904004-7D78E50E-7669-42B0-BA50-289103E5CE24Q37019061-11593D93-6C1E-4FD7-A77D-68F84D44B502Q37051227-FC4C4212-01C8-4A1C-A3DD-51B095C4E8EAQ37210782-C1186B46-05FF-40F7-B4F2-C0324EE1B23FQ37214680-FA4745A4-1788-481B-BD39-AE71C93791E8Q37225469-C7632078-B99A-4AA4-849F-A14E23A9CB2BQ37636429-36A6DB17-B890-4118-A7A4-88534835545CQ37741998-D9DC2A0A-6245-4E2A-85AE-68530C0FE07CQ37829411-CC47D2FA-5465-4604-B01E-5E0A5AA9DCC2Q37994133-E8492DE8-26BB-45D8-813D-66A8F2699E92Q38034447-C221BF10-EC20-4B3F-8782-D83A1DE01AB4Q38063574-29819763-1AF3-4D3F-964A-F836E37C4A27Q38063829-9A31D2AD-7EB4-4EDF-915F-F5E2D94096FBQ38092832-400D6F8D-C21C-41B7-BF55-4502EBA1E1CCQ38245352-3AE94BC2-90BA-49C6-AA37-B53FEEAFC2AFQ38659528-E19ED2F9-E16A-45B7-A875-FE538EB30C0CQ38846848-6C039B15-CB37-42D4-8A1F-75A226C17C18
P2860
Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Identification of five candida ...... f four lung cancer cell lines.
@ast
Identification of five candida ...... f four lung cancer cell lines.
@en
type
label
Identification of five candida ...... f four lung cancer cell lines.
@ast
Identification of five candida ...... f four lung cancer cell lines.
@en
prefLabel
Identification of five candida ...... f four lung cancer cell lines.
@ast
Identification of five candida ...... f four lung cancer cell lines.
@en
P2093
P2860
P50
P1476
Identification of five candida ...... f four lung cancer cell lines.
@en
P2093
Chris Planque
Chris R Smith
Lee Goodglick
P2860
P304
P356
10.1074/MCP.M900134-MCP200
P577
2009-09-23T00:00:00Z